아토피피부염에서 Endocannabinoid system (ECS) 조절을 통한 백호탕 추출물의 염증 완화 효과
Anti-inflammatory Effect of Baekho-tang Extract through Endocannabinoid system (ECS) Control in Atopic Dermatitis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives The aim of this study was to identify the effect of Baekho-tang extract on epidermal barrier recovery and inflammation relief in atopic dermatitis-induced mice through Endocanabinoid system (ECS) regulation. Methods In this study, we used 4-week-old NC/Nga mice were divided into 4 group: lipid barrier elimination group (LBEG), palmitoylethanolamide treated group after lipid barrier elimination (PEAT), Baekho-tang extract treatment group after lipid barrier elimination (BHTT) and control group (Ctrl). Each group was assigned 10 animals. We identified that cannabinoid receptor (CB) 1, CB2, CD (Cluster of Differentiation) 68, inducible nitric oxide synthase (iNOS), substance P and Matrix metallopeptidase 9 (MMP-9) through our immunohistochemistry. Results We discovered that when compared to PEAT, 8-hydroxydeoxyguanosine, a marker of oxidative stress in the epidermal barrier, and CB1 and CB2, markers of ECS modulation, were less activated in BHTT. These results led to an anti-inflammatory response in BHTT, with a significant decrease in several inflammatory mediators such as CD 68, iNOS, substance P and MMP-9 compared to PEAT and LBEG. Conclusions These results suggest that the Baekho-tang extract can reduce the inflammation of atopic dermatitis by restoring the structural damage of the skin lipid barrier through ECS modulation.
Abstract
Objectives The aim of this study was to identify the effect of Baekho-tang extract on epidermal barrier recovery and inflammation relief in atopic dermatitis-induced mice through Endocanabinoid system (ECS) regulation. Methods In this study, we used 4-week-old NC/Nga mice were divided into 4 group: lipid barrier elimination group (LBEG), palmitoylethanolamide treated group after lipid barrier elimination (PEAT), Baekho-tang extract treatment group after lipid barrier elimination (BHTT) and control group (Ctrl). Each group was assigned 10 animals. We identified that cannabinoid receptor (CB) 1, CB2, CD (Cluster of Differentiation) 68, inducible nitric oxide synthase (iNOS), substance P and Matrix metallopeptidase 9 (MMP-9) through our immunohistochemistry. Results We discovered that when compared to PEAT, 8-hydroxydeoxyguanosine, a marker of oxidative stress in the epidermal barrier, and CB1 and CB2, markers of ECS modulation, were less activated in BHTT. These results led to an anti-inflammatory response in BHTT, with a significant decrease in several inflammatory mediators such as CD 68, iNOS, substance P and MMP-9 compared to PEAT and LBEG. Conclusions These results suggest that the Baekho-tang extract can reduce the inflammation of atopic dermatitis by restoring the structural damage of the skin lipid barrier through ECS modulation.
참고문헌 (40)
- Silverberg JI, "Atopic dermatitis in the pediatric population : a cross-sectional, international epidemiologic study", Ann Allergy Asthma Immunol, 126(4), pp.417~428 (2021)
- 김현정, "아토피피부염과 피부 장벽 이상", Allergy Asthma & Respiratory Disease, 1(1), pp.20~28 (2013), 대한 소아알레르기 호흡기학회
- Schuler CF, "Novel insights into atopic dermatitis", J Allergy Clin Immunol, 151(5), pp.1145~1154 (2023)
- Bushlin I, "Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain", PLoS One, 7(12), pp.e49789~ (2012)
- Jung KM, "Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome", Nat Commun, 3, pp.1080~ (2012)
- Lu HC, "Review of the endocannabinoid system", Biol Psychiatry Cogn Neurosci Neuroimaging, 6(6), pp.607~615 (2021)
- Howlett AC, "The cannabinoid receptors", Prostaglandins Other Lipid Mediat, 68-69, pp.619~631 (2002)
- Hernandez-Cervantes R, "Immunoregulatory role of cannabinoids during infectious disease", Neuroimmunomodulation, 24(4-5), pp.183~199 (2017)
- Rieder SA, "Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression", Immunobiol, 215(8), pp.598~605 (2010)
- Suto H, "NC", Nga mice : a mouse model for atopic dermatitis, 1999, pp.120(1), 70~75
- 윤용갑, "아토피 피부염 치료제 개발에 활용할 수 있는 마우스 모델에 대한 고찰", 대한한의학 방제학회지, 15(1), pp.145~162 (2007), 대한한의학방제학회
- Seop HM, "Sanghanronjiphae", pp.301~578 (2005), Hakwon publisher
- 안상현, "백호탕 추출물의 지방장벽 손상 개선을 통한 상피 내 Th2 분화 조절 효과", 대한한방소아과학회지, 35(4), pp.156~166 (2021), 대한한방소아과학회
- In-Seung Lee, "The effects of Baekho-tang on 1-Fluoro-2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB", c mice, 2016, pp.16(4), 349~354[DOI]
- Lin CJ, "Bai-Hu-tang, ancient Chinese medicine formula, may provide a new complementary treatment option for sepsis", Evid Based Complement Alternat Med, 2013, pp.193084~ (2013)
- Brislinger D, "Bai Hu tang, Si Ni Tang, and Xue Bi tang amplify pro-inflammatory activities and reduce apoptosis in endothelial cells in a cell culture model of sepsis", J Ethnopharmacol, 28(225), pp.309~318 (2018)
- Jung AR, "Douchi (fermented Glycine max Merr.)alleviates atopic dermatitis-like skin lesions in NC", Nga mice by regulation of PKC and IL-4, 2016, pp.16(1), 416~
- David Boothe W, "Atopic dermatitis : pathophysiology", Adv Exp Med Biol, 1027, pp.21~37 (2017)
- Silverberg NB, "Inside out or outside in : does atopic dermatitis disrupt barrier function or does disruption of barrier function trigger atopic dermatitis?", Cutis, 96(6), pp.359~361 (2015)
- Frazier W, "Atopic dermatitis : diagnosis and treatment", Am Fam Physician, 101(10), pp.590~598 (2020)
- Bieber T, "Atopic dermatitis : an expanding therapeutic pipeline for a complex disease", Nat Rev Drug Discov, 21(1), pp.21~40 (2022)
- Kwiecień E, "Therapeutic potential of minor cannabinoids in dermatological Diseases—A synthetic review", Molecules, 28(16), pp.6149~ (2023)
- Eberlein B, "Adjuvant treatment of atopic eczema : assessment of an emollient containing N-palmitoylethanolamine(ATOPA study)", J Eur Acad Dermatol Venereol, 22(1), pp.73~82 (2008)
- Phan NQ, "Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia", J Dtsch Dermatol Ges, 8(2), pp.88~91 (2010)
- Kircik L, "A nonsteroidal lamellar matrix cream containing palmitoylethanolamide for the treatment of atopic dermatitis", J Drugs Dermatol, 9(4), pp.334~338 (2010)
- Petrosino S, "Protective role of palmitoylethanolamide in contact allergic dermatitis", Allergy, 65(6), pp.698~711 (2010)
- Yuan C, "N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema : results of a randomized, double-blind, controlled study in 60 patients", Clin Interv Aging, 9, pp.1163~1169 (2014)
- Paloczi J, "Neuroprotection in oxidative stress-related neurodegenerative diseases : role of endocannabinoid system modulation", Antioxid Redox Signal, 29(1), pp.75~108 (2018)
- Di Carlo M, "Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases?", Free Radic Res, 46(11), pp.1327~1338 (2012)
- Pasparakis M, "Mechanisms regulating skin immunity and inflammation", Nat Rev Immunol, 14(5), pp.289~301 (2014)
- Barros MH, "Macrophage polarisation : an immunohistochemical approach for identifying M1 and M2 macrophages", PLoS One, 8(11), pp.e80908~ (2013)
- Shelburne CP, "The role of Th2 cytokines in mast cell homeostasis", Immunol Rev, 179(1), pp.82~93 (2001)
- Lacraz S, "Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4", J Clin Invest, 90(2), pp.382~388 (1992)
- O’Connor TM, "The role of substance P in inflammatory disease", J Cell Physiol, 201(2), pp.167~180 (2004)
- Medeiros R, "Reduced skin inflammatory response in mice lacking inducible nitric oxide synthase", Biochem Pharmacol, 78(4), pp.390~395 (2009)
- 정미림, "Effects of Ethanol Extracts of Anemarrhena asphodeloides on Skin Barrier Function by Inflammation", 한방안이비인후피부과학회지, 31(2), pp.11~23 (2018), 대한한방안이비인후피부과학회[DOI]
- Makino T, "Interaction of gypsum and the rhizome of Anemarrhena asphodeloides plays an important role in anti-allergic effects of byakkokakeishito in mice", J Nat Med, 68(3), pp.505~512 (2014)
- Hwang SJ, "The experience with treating Soyang type’s diabetes through Baekho-tang", J Sasang Constitut Med, 6(1), pp.19~20 (1994)
- 박혜진, "뇌경색 이후 발생한 위완통의 백호탕 치험 1례 증례보고", 한의학연구소 논문집, 21(2), pp.113~138 (2013), 한의학연구소
- Lin CJ, "Bai-Hu-tang, ancient Chinese medicine formula, may provide a new complementary treatment option for sepsis", Evid Based Complement Alternat Med, 2013, pp.193084~ (2013)
